Trior tetraspecific antibodies

Details for Australian Patent Application No. 2010252284 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Croasdale, Rebecca; Klein, Christian; Schaefer, Wolfgang; Schanzer, Juergen Michael

Agent Griffith Hack

Pub. Number AU-A-2010252284

PCT Pub. Number WO2010/136172

Priority 09007052.5 27.05.09 EP

Filing date 25 May 2010

Wipo publication date 2 December 2010

International Classifications

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07K 16/22 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

Event Publications

17 November 2011 PCT application entered the National Phase

  PCT publication WO2010/136172 Priority application(s): WO2010/136172

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010252297-Anti-oomycetes

2010252280-Continuous administration of cilengitide in cancer treatments